![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1699337
°¨¿° °ü¸®¿ë °³Àκ¸È£±¸(PPE) ½ÃÀå ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м®, ¿¹Ãø(2025-2034³â)Personal Protective Equipment for Infection Control Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 |
¼¼°èÀÇ °¨¿° °ü¸®¿ë °³Àκ¸È£±¸(PPE) ½ÃÀåÀº 2024³â¿¡ 210¾ï ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, 2025³âºÎÅÍ 2034³â±îÁö 3.7%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.
PPE´Â ƯÈ÷ º´¿ø, ¿¬±¸¼Ò, Ŭ¸®´Ð, »ê¾÷ Á÷Àå µîÀÇ À§ÇèÀÌ ³ôÀº ȯ°æ¿¡¼ °¨¿°ÀÇ È®»êÀ» ÃÖ¼ÒÈÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. º¸È£ Àåºñ¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¼ö¿ä´Â COVID-19¿Í µ¶°¨À» Æ÷ÇÔÇÑ °¨¿°ÀÇ À¯ÇàÀÌ Áõ°¡Çϰí ÀÖ´Ù´Â ¹è°æÀÔ´Ï´Ù. ¶ÇÇÑ, Ç×±Õ ÅØ½ºÅ¸ÀÏ¿Í ÀÎü°øÇÐÀû ±â´ÉÀÇ ¹ßÀüÀ¸·Î PPEÀÇ ÄèÀû¼º°ú ±â´É¼ºÀÌ Çâ»óµÇ¾î ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
2023³â ½ÃÀå ±Ô¸ð´Â 217¾ï ´Þ·¯¸¦ ±â·ÏÇØ ¼Õ°ú ÆÈ º¸È£±¸°¡ Áö¹èÀûÀÎ ºÎ¹®À¸·Î ºÎ»óÇÏ¿© 2024³â ¸ÅÃâÀÇ 45.2%¸¦ Â÷ÁöÇß½À´Ï´Ù. °Ç°°ü¸® °ü·Ã °¨¿°(HAI) Áõ°¡·Î È¿°úÀûÀÎ º¸È£±¸, ƯÈ÷ ³»±¸¼º, Ã˰¢°¨µµ, ³»¾àǰ¼ºÀ» °ÈÇÑ Àå°©ÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ ºÐ¾ß´Â PPE ¼ÒÀç¿¡ ´ëÇÑ ÀǽÄÀÇ °íÁ¶¿Í ±â¼ú °³·®¿¡ ÀÇÇØ ¿¹Ãø ±â°£ Áß¿¡ ´ëÆøÀûÀÎ È®´ë°¡ Àü¸ÁµÇ°í ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§ | |
---|---|
½ÃÀÛ ¿¬µµ | 2024³â |
¿¹Ãø ¿¬µµ | 2025-2034³â |
½ÃÀÛ ±Ý¾× | 210¾ï ´Þ·¯ |
¿¹Ãø ±Ý¾× | 294¾ï ´Þ·¯ |
CAGR | 3.7% |
½ÃÀåÀº ÀÏȸ¿ë PPE¿Í Àç»ç¿ë °¡´ÉÇÑ PPE·Î ³ª´µ¸ç, 2024³â¿¡´Â ÀÏȸ¼º ºÐ¾ß°¡ 162¾ï ´Þ·¯·Î ¼±µÎ¿¡ ÀÖ¾ú½À´Ï´Ù. ÇコÄɾî ÀÎÇÁ¶óÀÇ °è¼ÓÀûÀÎ È®´ë¿¡ ÀÇÇØ °¨¿° ´ëÃ¥ ¿ëǰÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖ´Â °Íµµ, ¼ö¿ä¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.
ÃÖÁ¾ ¿ëµµº°·Î º´¿øÀÌ ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç 2024³â ¸ÅÃâ¾×Àº 126¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ƯÈ÷ ¼ö¼ú°ú ÀÇ·á ÀýÂ÷ÀÇ ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó °íǰÁú º¸È£ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.
¹Ì±¹¿¡¼´Â °¨¿° °ü¸®¿ë °³Àκ¸È£±¸(PPE) ½ÃÀåÀÌ 2024³â¿¡ 88¾ï ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, 2034³â¿¡´Â 120¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. AIÀÇ ÀÌȯÀ²ÀÌ »ó½ÂÇϰí ÀÖ´Â °ÍÀÌ °¨¿°Á¦¾î Á¦Ç°ÀÇ Çʿ伺À» ´õ¿í ³ô¿©ÁÖ°í ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ °ø±Þǰ¿¡ ´ëÇÑ ¼ö¿ä´Â 2032³â±îÁö 630¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù.
The Global Personal Protective Equipment For Infection Control Market was valued at USD 21 billion in 2024 and is expected to grow at a 3.7% CAGR from 2025 to 2034. PPE plays a critical role in minimizing the spread of infectious diseases, especially in high-risk settings such as hospitals, laboratories, clinics, and industrial workplaces. The continuous demand for protective equipment is driven by the increasing prevalence of infectious diseases, including COVID-19 and influenza. Additionally, advancements in antimicrobial textiles and ergonomic features have enhanced the comfort and functionality of PPE, contributing to market growth.
With the market valued at USD 21.7 billion in 2023, hand and arm protection equipment emerged as the dominant segment, accounting for 45.2% of revenue in 2024. The increasing cases of healthcare-associated infections (HAIs) have heightened the need for effective protective gear, particularly gloves with enhanced durability, tactile sensitivity, and chemical resistance. The segment is anticipated to experience significant expansion over the forecast period due to growing awareness and technological improvements in PPE materials.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $21 Billion |
Forecast Value | $29.4 Billion |
CAGR | 3.7% |
The market is divided into disposable and reusable PPE, with the disposable segment leading at USD 16.2 billion in 2024. Disposable PPE remains a preferred choice in healthcare facilities due to strict regulatory recommendations from organizations such as the CDC and WHO. The demand is further fueled by the continuous expansion of healthcare infrastructure, reinforcing the necessity for infection control supplies. The growing emphasis on reducing cross-contamination and improving hygiene standards is expected to drive the segment's growth.
By end use, hospitals captured the largest market share, generating USD 12.6 billion in revenue in 2024. Hospitals prioritize investment in PPE to safeguard healthcare workers and patients from infectious threats. Infection control measures, including PPE usage, are crucial for reducing the risk of disease transmission in medical facilities. The rising number of surgical and medical procedures also amplifies the demand for high-quality protective equipment. The segment is expected to maintain steady growth throughout the forecast period as healthcare providers continue to prioritize safety and compliance with infection control protocols.
In the United States, the PPE for infection control market was valued at USD 8.8 billion in 2024 and is projected to reach USD 12 billion by 2034. The country enforces strict infection control policies through OSHA, the CDC, and the FDA, ensuring adherence to PPE guidelines in healthcare environments. The rising incidence of HAIs further drives the need for infection control products, with demand for these supplies expected to reach USD 63 billion by 2032. The strong regulatory framework, coupled with the emphasis on healthcare safety, positions the US market for consistent growth in the coming years.